These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38012656)

  • 1. Clinical, molecular, and histological characteristics of severely necrotic and fatal mpox in HIV-infected patients.
    Rajme-López S; Corral-Herrera EA; Tello-Mercado AC; Tepo-Ponce KM; Pérez-Meléndez RE; Rosales-Sotomayor Á; Figueroa-Ramos G; López-López K; Domínguez-Cherit JG; San-Martín-Morante O; Saeb-Lima M; Gamboa-Domínguez A; Ponce-de-León A; Crabtree-Ramírez B; Ramos-Cervantes P; Ruíz-Palacios GM
    AIDS Res Ther; 2023 Nov; 20(1):85. PubMed ID: 38012656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV viral load monitoring during monkeypox virus infection among people with HIV.
    Raccagni AR; Mileto D; Galli L; Bruzzesi E; Canetti D; Rizzo A; Bertoni C; Clemente T; Alberton F; Castagna A; Nozza S
    AIDS; 2023 Apr; 37(5):779-783. PubMed ID: 36689645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak.
    Azzam A; Khaled H; Salem H; Ahmed A; Heniedy AM; Hassan HS; Hassan A; El-Mahdy TS
    Virol J; 2024 Jun; 21(1):130. PubMed ID: 38840177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mpox and HIV: a Narrative Review.
    Saldana CS; Kelley CF; Aldred BM; Cantos VD
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.
    Pinnetti C; Cimini E; Mazzotta V; Matusali G; Vergori A; Mondi A; Rueca M; Batzella S; Tartaglia E; Bettini A; Notari S; Rubino M; Tempestilli M; Pareo C; Falasca L; Del Nonno F; Scarabello A; Camici M; Gagliardini R; Girardi E; Vaia F; Maggi F; Agrati C; Antinori A
    Lancet Infect Dis; 2024 Feb; 24(2):e127-e135. PubMed ID: 37778364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical course of Mpox among HIV-negative and HIV-positive patients: A 2022 cohort of hospitalized patients in Central Europe.
    Kowalski J; Cielniak I; Garbacz-Łagożna E; Cholewińska-Szymańska G; Parczewski M
    J Med Virol; 2023 Oct; 95(10):e29172. PubMed ID: 37861345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.
    Ogoina D; Dalhat MM; Denue BA; Okowa M; Chika-Igwenyi NM; Yusuff HA; Christian UC; Adekanmbi O; Ojimba AO; Aremu JT; Habila KL; Oiwoh SO; Tobin EA; Johnson SM; Olaitan A; Onyeaghala C; Gomerep SS; Alasia D; Onukak AE; Mmerem J; Unigwe U; Falodun O; Kwaghe V; Awang SK; Sunday M; Maduka CJ; Na'uzo AM; Owhin SO; Mohammed AA; Adeiza MA;
    Lancet Infect Dis; 2023 Dec; 23(12):1418-1428. PubMed ID: 37625431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological characteristics, clinical manifestations, and mental health status of human mpox cases: A multicenter cross-sectional study in China.
    Fu L; Wang B; Wu K; Yang L; Hong Z; Wang Z; Meng X; Ma P; Qi X; Xu G; Wang F; Zhang W; Huang C; Zhang D; Lin Y; Cao W; Sun P; Wu W; Gao Y; Lv F; Qian J; Lu H; Zou H
    J Med Virol; 2023 Oct; 95(10):e29198. PubMed ID: 37881113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Presentation of Mpox in People With and Without HIV in the United Kingdom During the 2022 Global Outbreak.
    Pilkington V; Quinn K; Campbell L; Payne L; Brady M; Post FA
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):581-586. PubMed ID: 37071153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Mpox Disease in People With Advanced HIV: Characterization of Mpox Skin Lesions.
    O'Shea J; Zucker J; Stampfer S; Cash-Goldwasser S; Minhaj FS; Dretler A; Cheeley J; Chaudhuri S; Gallitano SM; Gunaratne S; Parkinson M; Epling B; Morcock DR; Sereti I; Deleage C
    J Infect Dis; 2024 Mar; 229(Supplement_2):S243-S248. PubMed ID: 38019806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Mpox Infections in People With Uncontrolled Human Immunodeficiency Virus.
    Govind A; Lazarte SM; Kitchell E; Chow JY; Estelle CD; Fixsen E; Helm C; Jain MK; Mehta R; Perl TM; Sutaria JM; Thomas C; Dominguez AR; Utay NS
    Clin Infect Dis; 2023 May; 76(10):1843-1846. PubMed ID: 36718662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.
    Essajee NM; Oddo-Moise H; Hagensee ME; Lillis RA; Maffei J; Butler I; Lovett A; Sokol T; Clement ME
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):587-592. PubMed ID: 37424520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology and Monkeypox virus Localization in Tissues From Immunocompromised Patients With Severe or Fatal Mpox.
    Ritter JM; Martines RB; Bhatnagar J; Rao AK; Villalba JA; Silva-Flannery L; Lee E; Bullock HA; Hutson CL; Cederroth T; Harris CK; Hord K; Xu Y; Brown CA; Guccione JP; Miller M; Paddock CD; Reagan-Steiner S;
    J Infect Dis; 2024 Mar; 229(Supplement_2):S219-S228. PubMed ID: 38243606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of fatal monkeypox infection: necropsy and molecular findings, with some considerations related to clinical management.
    Paniagua-García M; Casimiro-Soriguer CS; Chinchón D; Navarro-Amuedo MD; Luque-Márquez R; de Álava E; Lepe JA; Cisneros JM
    Clin Microbiol Infect; 2024 Mar; 30(3):395.e1-395.e4. PubMed ID: 38042367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Failure in Patient with Severe Mpox and Untreated HIV, Maryland, USA.
    Filippov E; Duhan S; Lehman L; Keisham B; Sethi V
    Emerg Infect Dis; 2023 Jun; 29(6):1262-1265. PubMed ID: 37172298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prolonged Case of Severe Mpox as an Opportunistic Infection in Advanced AIDS.
    Malka MS; Parkinson M; Zucker J; McLean JR; Pereira MR; Yin MT; Gunaratne SH
    Cureus; 2024 May; 16(5):e59947. PubMed ID: 38854169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long or complicated mpox in patients with uncontrolled HIV infection.
    Corma-Gómez A; Cabello A; Orviz E; Morante-Ruiz M; Ayerdi O; Al-Hayani A; Muñoz-Gómez A; Santos IL; Gómez-Ayerbe C; Rodrigo D; Riestra SR; Reus-Bañuls S; Silva-Klug A; Galindo MJ; Santos M; Serrano-Fuentes M; Faro-Míguez N; Pérez-Camacho I; Corona-Mata D; Morano L; López-Ruz MÁ; Montero M; Anaya-Baz B; Merino D; Castillo-Navarro A; Pineda JA; Macías J
    J Med Virol; 2024 Mar; 96(3):e29511. PubMed ID: 38469884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged, Atypical, and Fulminant Mpox in a HIV/HBV-Coinfected Patient: A Case Report.
    Perez-Hernandez FJ; Alvarez-Sanchez VA; Torres-Erazo D; Ceballos-Perez M; Franco-Gonzalez CD
    Cureus; 2024 Jan; 16(1):e52043. PubMed ID: 38344579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.